Skip to main content

Breadcrumb

  1. Home

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Surveillance AFter Extremity Tumor surgerY

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Surveillance AFter Extremity Tumor surgerY

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCEĀ®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCEĀ®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 217
  • Page 218
  • Page 219
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • Page 224
  • Page 225
  • …
  • Next page Next
  • Last page Last
Subscribe to